Financial News · Live Terminal

Page 1 of 1137

Aspial Lifestyle's H1 Attributable Profit Surges 88%

Aspial Lifestyle's (SGX:5UF) recorded an 88% rise in attributable profit in the first half of 2026 to SG$52.4 million from SG$27.9 million a year prior.Earnings per share stood at SG$0.0277, up from SG$0.015 previously, according to a Friday filing with the Singapore bourse.Revenue jumped 26% to SG$464.2 million from SG$367.2 million in the year-ago period.

SGX:5UF

Asia20h ago

Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug

Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group's Benmelstobart Injection obtained marketing approval from China's National Medical Products Administration, according to a Friday Hong Kong bourse filing.The approval is for use of the drug in combination with chemotherapy and sequentially followed by Anlotinib Hydrochloride Capsules for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer.

HKG:1177

Asia20h ago

Lygend Resources Gets CSRC Nod for China Listed-Share IPO

Lygend Resources & Technology (HKG:2245) obtained approval for its registration application related to its China listed-share initial public offering from the China Securities Regulatory Commission (CSRC).The share offering is subject to various conditions, including certain final regulatory approvals, according to a Friday Hong Kong bourse filing.

Financial News · Live Terminal

Aspial Lifestyle's H1 Attributable Profit Surges 88%

Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug

Lygend Resources Gets CSRC Nod for China Listed-Share IPO

Zhongliang Logs 380 Million Yuan in July Contracted Sales

Longfor Logs 2.09 Billion Yuan in July Contracted Sales

Beng Kuang Marine's Profit Jumps 21% in H1

Alebund Pharma's Application for Hyperphosphatemia Drug Accepted in China

Morimatsu International Holdings Warns of H1 Loss

Tianneng Power International Warns of Up to 66% Lower H1 Profit

Titan's Consolidated Profit Rises in Fiscal Q1

Market Chatter: Sojitz Eyes Increased Beef Output in Vietnam

Nomura Adjusts SATS' Price Target to SG$5.59 From SG$4.57, Keeps at Buy

Pateo Connect Technology to Acquire 70% Interest in Communications Chip Company

Canadian Government to Invest C$10 Million in Hanon Systems for Ontario Manufacturing Plant

FS.com Proposes Share Incentive Scheme

Ho Bee Land's Attributable Profit, Revenue Rise in H1

Shenzhou International Warns of Up to 43% Lower H1 Profit

China Resources Gas Sells 2.5 Billion Yuan Bonds

Wiwynn Books H1 Attributable Profit of NT$29 Billion

Getac's Revenue Jumps 16% in July

Aspial Lifestyle's H1 Attributable Profit Surges 88%

Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug

Lygend Resources Gets CSRC Nod for China Listed-Share IPO

Zhongliang Logs 380 Million Yuan in July Contracted Sales

Longfor Logs 2.09 Billion Yuan in July Contracted Sales

Beng Kuang Marine's Profit Jumps 21% in H1

Alebund Pharma's Application for Hyperphosphatemia Drug Accepted in China

Morimatsu International Holdings Warns of H1 Loss

Tianneng Power International Warns of Up to 66% Lower H1 Profit

Titan's Consolidated Profit Rises in Fiscal Q1

Market Chatter: Sojitz Eyes Increased Beef Output in Vietnam

Nomura Adjusts SATS' Price Target to SG$5.59 From SG$4.57, Keeps at Buy

Pateo Connect Technology to Acquire 70% Interest in Communications Chip Company

Canadian Government to Invest C$10 Million in Hanon Systems for Ontario Manufacturing Plant

FS.com Proposes Share Incentive Scheme

Ho Bee Land's Attributable Profit, Revenue Rise in H1

Shenzhou International Warns of Up to 43% Lower H1 Profit

China Resources Gas Sells 2.5 Billion Yuan Bonds

Wiwynn Books H1 Attributable Profit of NT$29 Billion

Getac's Revenue Jumps 16% in July